Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;108(10):163-9.
doi: 10.3238/arztebl.2010.0163. Epub 2011 Mar 11.

Survival analysis: part 15 of a series on evaluation of scientific publications

Affiliations

Survival analysis: part 15 of a series on evaluation of scientific publications

Isabella Zwiener et al. Dtsch Arztebl Int. 2011 Mar.

Abstract

Background: Survival times are often used to compare treatments. Survival data are a special type of data, and therefore have to be analyzed with special methods.

Methods: We illustrate special techniques for analyzing survival times by applying them to a publication on the treatment of patients with brain tumors. The present article is based on textbooks of statistics, a selective review of the literature, and the authors' own experience.

Results: Survival times are analyzed with the Kaplan-Meier method, which yields two measures of interest: survival rates and the median survival time. The log-rank test is used to compare survival times across treatment groups. Cox regression is used in multivariable models. The hazard ratio, a descriptive measure for differences in survival times, is explained.

Conclusion: If survival times are analyzed without the use of special techniques, or if the underlying assumptions are not taken into account, faulty interpretation may result. Readers of scientific publications should know these pitfalls and be able to judge for themselves whether the chosen analytical method is correct.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Kaplan–Meier curve for 33 children and adolescents with medulloblastoma and metastasis status M1
None

Similar articles

Cited by

References

    1. von Hoff K, Hinkes B, Gerber NU, Deinlein F, Mittler U, Urban C, et al. Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT’91. EJC. 2009;45:1209–1217. - PubMed
    1. Weiß C. Basiswissen Medizinische Statistik. 5th revised edition. Heidelberg: Springer Medizin Verlag; 2010.
    1. Schumacher M, Schulgen G. Methodik klinischer Studien. 3rd edition. Berlin, Heidelberg, New York: Springer; 2008.
    1. Collett D. Modelling survival data in medical research. 2nd edition. London: Chapman and Hall; 2003.
    1. Kalbfleisch JD, Prentice R. The statistical analysis of failure time data. 2nd edition. New York Wiley,: 2002.